Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/10/2026 to consider and approve fund raising by way of issuance of Non-Convertible Debentures and modification/change in security in respect of Tranche II of Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non-Convertible Debentures.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the voting results of its 19th Annual General Meeting (AGM) held on September 30, 2026. The meeting was conducted through video conferencing, and the voting results were announced in accordance with Regulation 44(3) of SEBI (LODR) Regulations, 2015. The company has reported that all resolutions were passed with a high percentage of votes in favor, with some shareholders abstaining or not voting on certain resolutions.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd held its 19th Annual General Meeting (AGM) on September 30, 2026, through video conferencing. The meeting was attended by the required quorum, and resolutions related to the adoption of audited financial statements, re-appointment of a director, and re-appointment of statutory auditors were passed with the required majority.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the Scrutinizer's Report for the Shareholder Meeting/Postal Ballot, confirming the outcome of the meeting and the voting results.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the allotment of 1,500 Senior, Secured, Rated, Listed, Redeemable, Transferable, Taxable Non-Convertible Debentures worth INR 15,00,00,000/- through private placement.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the closure of its trading window for the quarter ending 30th September, 2026, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the announcement of the un-audited financial results for the quarter and half year ending 30th September, 2026.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd's wholly owned subsidiary, CARBOGEN AMCIS AG, has successfully completed a US FDA inspection at its manufacturing site in Switzerland without any observations.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the 19th Annual General Meeting (AGM) to be held through video conferencing or other audio visual means on September 30, 2026. The company has also invited tenders for upgradation and beautification works of Shoolenwar Narmada Ghat in Gujarat.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the date of its 19th Annual General Meeting (AGM) to be held on September 30, 2026, through video conferencing.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the cessation of Mr. Deepak Ram Chandra Mittal as Vice President (Operation) with effect from 27th August, 2026.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd announced its Q1 FY27 earnings results, with CEO Stephan Fritschi discussing operational updates, sales activities, and business unit performance. The company hired a new Global Chief Commercial Officer, Angela Ameriks, and strengthened its sales force. The SPRINT initiative was successful, and the packaged drug substance product showed high interest from customers. The company also increased interaction between Dishman Carbogen Amcis and Carbogen Amcis, with multiple processes being transferred from Carbogen to Dishman in India.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has made the audio recording of its earnings conference call on August 17, 2026, available on its website, as per SEBI regulations.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the allotment of 7,500 senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures of face value of INR 1,00,000 each, aggregating to INR 75,00,00,000, through private placement.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd reported a 4.29% decline in net revenue to ₹6,776 million in Q1 FY27, primarily due to deferment of CDMO revenue, partly offset by growth in the Marketable Molecules segment.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced its unaudited financial results for the quarter ended 30/06/2026. The company reported a total income of ₹2,931.90, expenses of ₹2,879.14, and a profit/(loss) of ₹(49.53). The company's net profit/(loss) for the quarter is ₹(51.22).

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced its unaudited financial results for the quarter ended 30/06/2026, with a net profit of (Rs. 38.62 crores) and a total income of Rs. 695.80 crores.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has arranged a conference call with investors on August 17, 2026, to discuss its Q1FY27 financial results and performance.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has arranged a conference call with investors on August 17th to discuss its Q1FY27 financial results.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has announced the approval of the Board of Directors to issue up to Rs. 75 crores of senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures on a private placement basis.

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the un-audited financial results of the Company for the first quarter ended on 30th June, 2026.